Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284128 · ClinicalTrials.gov registry record · Phase 2
AVE7688 in Patients With Mild to Moderate Blood Pressure
A Phase 2 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,940
- Enrollment target
NCT00284128 is a Phase 2 study that has completed, run by Sanofi. The registered enrollment target is 1,940 participants.
The verdict
NCT00284128, a Phase 2 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,940 participants
- Enrollment target
Study Summary
The primary objective is to assess the antihypertensive efficacy of 4 different AVE 7688 doses on the change from baseline in trough diastolic blood pressure at the end of week 12. The secondary objectives are: * To assess the antihypertensive efficacy of 4 different AVE 7688 doses on the change from baseline in trough systolic blood pressure at the end of week 12 * To compare the percentages of responders after 12 week of treatment * To evaluate the long term safety and tolerability of AVE 7688 with particular attention to angioedema
Interventions
- DRUG AVE7688
- DRUG Losartan-potassium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,940 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00284128
The ClinicalTrials.gov registry entry for NCT00284128 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,940 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AVE7688 is the first listed.
NCT00284128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00284128 about?
NCT00284128 is a clinical study titled "AVE7688 in Patients With Mild to Moderate Blood Pressure". The primary objective is to assess the antihypertensive efficacy of 4 different AVE 7688 doses on the change from baseline in trough diastolic blood pressure at the end of week 12. The secondary objectives are: * To assess the antihypertensive efficacy of 4 different AVE 7688 doses on the change f...
What is the current status of trial NCT00284128?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,940 participants. The study started on 2005-12. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00284128?
The interventions under investigation include: AVE7688 (DRUG), Losartan-potassium (DRUG).
Who is sponsoring clinical trial NCT00284128?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.